NEWSROOM
Discover all the actions carried out by Jeito and all the partnerships that we set up day after day for the well-being of patients and medical progress.
In the headlines
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion
This acquisition reflects the significant clinical progress achieved with Restoret™,EyeBio’s novel late-phase candidate for diabetic macular edema,as well as a preclinical pipeline targeting retinal diseases - Restoret anticipated to enter pivotal study for diabetic...
Download our White Paper
We are pleased to share with you our White Paper, which offers a deep dive into the evolving biopharma landscape and highlights the key trends shaping its future.
Find all our press releases
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide
Jeito selects Pulmocide as its fourth investment since launching the fund Pulmocide is a...
First Year-in-Review: Jeito Capital confirms strength of its investment model and 2021 ambitions with more deals and significant capital
The investment fund confirms the strength of its investment model in medical innovation, closing...
Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and leader in rare skeletal disorders
Jeito’s third international investment in H2 2020, with deep and rapidly accelerating pipeline...
Sanofi selects Jeito Capital as its first investment into a private French-based fund
Paris, France, 13 November 2020 – Jeito Capital (“Jeito”), a rapidly emerging independent investor...
Jeito Capital becomes major investor in SparingVision as part of €44.5 Million financing
Jeito Capital has selected SparingVision as its first French investment following the fund I...
Rafaèle Tordjman, Founder and CEO of Jeito, is awarded Chevalier of the Légion d’Honneur
Paris, France, 30 September 2020 – Jeito Capital (“Jeito”), a rapidly emerging independent...
Face to face
Meet Jeito
16-17
December
All day long
Conference of Paris 2024
Jeito will be present at the Conference of Paris 2024, for its 8th edition around the theme “Confronting the Unknown”, encouraging leaders to share their knowledge and understanding of global economic, social and environmental issues as a way to collaborate and collectively overcome these challenges.
13-16
January
All day long
JPM Healthcare Conference 2025
Jeito will be present at the 43rd JPM Healthcare Conference 2025, renowned as the largest and most influential healthcare investment symposium, attracting global industry leaders, Biotech companies, and members of the investment community, in San Francisco.
28-30
January
All day long
IPEM Cannes 2025
Jeito will be present at the 11th edition of IPEM Cannes – Wealth 2025, gathering Private Capital key decision-makers and incubating this year “IPEM Wealth”, a brand-new format designed to support the democratization of Private Markets, in Cannes.